Skip to content

CG Oncology CGON Tax on Share Settlement

Tax on Share Settlement at other companies

ImmunityBio, Inc. logo
ImmunityBio, Inc.IBRX
$6.99M+482%
Cogent Biosciences, Inc. logo
Cogent Biosciences, Inc.COGT
$12.22M
Exelixis logo
ExelixisEXEL
$34.23M+52.0%
Biogen logo
BiogenBIIB
$55.1M+127%
Incyte logo
IncyteINCY
$6.96M-26.4%
Corcept Therapeutics logo
Corcept TherapeuticsCORT
$5.76M-63.6%

Other financials

Income statement

See full
Revenue$1.1M+1,983%
Operating income-$66.4M-57.3%
Net income-$60.2M-74.7%
EPS (diluted)-$0.71-57.8%

Balance sheet

See full
Cash & equivalents$33.7M-18.7%
Total debt$7.6M+631%
Total equity$1.1B+54.9%
Total assets$1.1B+55.9%

Cash flow

See full
Operating cash flow-$56.9M-94.5%
CapEx$304.0K+1,800%
Free cash flow-$57.2M-95.4%

Valuation

See full
Market cap$5.39B+206%
Enterprise value$5.36B+212%
P/S1,062.4×-1,596×

Profitability

See full
Operating margin-4,239%-1,872pp
Net margin-3,682.6%-1,601pp
FCF margin-3,163.8%-1,351pp

Returns & leverage

See full
Return on equity-20.8%+7.1pp
Debt / equity0.0×
Current ratio31.3×+0.3×

Where this comes from

Reported directly by CG Oncology in its filing.

Tagged under the XBRL concept us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation.

The official record: CG Oncology’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about CG Oncology's tax on share settlement.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is CG Oncology's tax on share settlement?
CG Oncology (CGON) reported tax on share settlement of $174K in Q1 2026.
What does tax on share settlement mean?
Cash paid to tax authorities for employee share vesting, where the company withholds shares and pays the tax obligation in cash.